Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use VENCLEXTA safely and effectively. See full prescribing information for VENCLEXTA. VENCLEXTA ® (venetoclax tablets), for oral use Initial U.S. Approval: 2016
Medication labelWhy this: Advisory · dailymed-prescription
VENCLEXTA is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). VENCLEXTA is indicated in combination with azacitidine, or decitabine, or low-dose cytarabine for the treatment of newly diagnosed acute myeloid leukemia (AML) in adults 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy.
- generic_name
- venetoclax
- product_names
- Venetoclax
- ndc
- 0074-0579, 0074-0579-28, 0074-0561, 0074-0566, 0074-0576, 0074-0576-22, 0074-0576-11, 0074-0576-34, 0074-0576-30, 0074-0561-14, 0074-0561-11, 0074-0566-07, 0074-0566-11
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en